Frazier Life Sciences VIII, L.P. - Significant Ownership

Signature - Title
/s/ Steve R. Bailey - By Steve R. Bailey, CFO of FHM Life Sciences VIII, L.L.C., GP of FHM Life Sciences VIII, L.P., GP of Frazier Life Sciences VIII, L.P.
Location
Seattle, WA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Frazier Life Sciences VIII, L.P..

Significant Ownership of Frazier Life Sciences VIII, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARQT ARCUTIS BIOTHERAPEUTICS, INC. Common Stock, par value $0.0001 per share 7.5% $142M 8.94M Patrick J. Heron Aug 18, 2025

Schedules 13D/G Reported by Frazier Life Sciences VIII, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.